Dr. Aaron S. Mansfield is a medical oncologist whose focus on thoracic malignancies and early therapeutics has led to significant improvements in outcomes for mesothelioma patients. He is co-director of the Precision Cancer Therapeutics Program within the Mayo Clinic Center for Individualized Medicine.

Dr. Abraham Chachoua is a medical oncologist and Director of the Lung Cancer Center at the Perlmutter Cancer Center of NYU Langone Hospital in New York. He specializes in the treatment of cancers of the lung and chest, including malignant pleural mesothelioma.

Dr. Lebenthal is an expert in mesothelioma surgery, having trained under Dr. David Sugarbaker in general thoracic surgery at the Brigham and Women’s hospital. He is himself a veteran and currently works at the Harvard and Boston University-affiliated West Roxbury VA hospital, where he is pleased to give back to a community that has given so much for its country. [19]

Dr. Adam Lackey is a board-certified thoracic surgical oncologist who specializes in minimally invasive thoracic surgery for the treatment of lung cancer, chest wall tumors, and diseases of the pleural space, including malignant pleural mesothelioma. He practices at RWJ Barnabas Health in Jersey City, New Jersey.

Dr. Afshin Dowlati is a medical oncologist and researcher specializing in thoracic malignancies at the University Hospitals Seidman Cancer Institute. His specialty is treating small-cell lung cancer and malignant pleural mesothelioma. In addition to clinical management of patients, he conducts research into better treatment options for these challenging conditions.

Dr. Alan Dal Pra is a radiation oncologist and researcher at the Sylvester Comprehensive Cancer Center at the University of Miami, Miller School of Medicine. His clinical specialty is the application of state-of-the-art radiation therapies to treat thoracic tumors, including lung cancer and mesothelioma.

Dr. Alberto Chiappori is a thoracic oncologist who uses innovative immunotherapy in combination with chemotherapy to treat patients with lung cancers and malignant pleural mesothelioma at Moffitt Cancer Center and Research Institute in Tampa, Florida.

Dr. Alex Spira is a medical oncologist who treats patients diagnosed with lung cancer and malignant pleural mesothelioma, as well as other thoracic cancers, at Virginia Cancer Specialists in Fairfax, Virginia.

Dr. Alexander S. Farivar is a cardiothoracic and thoracic surgeon who specializes in treating patients diagnosed with lung cancer, esophageal cancer, and malignant pleural mesothelioma. He deploys his skill in the use of robotic surgery and other minimally invasive surgical techniques at the Swedish Medical Center in Seattle, Washington.

Dr. Alexandra Funaki is a radiologist who specializes in diagnosing malignant pleural mesothelioma, lung cancer, and other thoracic diseases at the University of Chicago’s Duchossois Center for Advanced Medicine in Hyde Park, Illinois.

Dr. Alexandra Gangi is a surgical oncologist at Cedars-Sinai and its Samuel Oschin Comprehensive Cancer Center in Los Angeles, California. She specializes in treating patients with gastrointestinal and abdominal cancers, as well as malignancies like peritoneal mesothelioma.

Dr. Alice M. Boylan is an acute, critical, and trauma care physician in the division of Pulmonary and Critical Care at the Medical University of South Carolina in Charleston, South Carolina. She specializes in the care of critically ill patients, with a special focus on malignant pleural mesothelioma, lung cancer, and other asbestos-related lung diseases.

Dr. Alissa Greenbaum is a surgical oncologist at the University of New Mexico’s Comprehensive Cancer Center and Health Sciences Center. She specializes in treating patients with gastrointestinal and peritoneal malignancies including peritoneal mesothelioma.

Dr. Amin Mirhadi is a highly-respected radiation oncologist at Cedars-Sinai Samuel Oschin Comprehensive Cancer Center. He applies his skills and the most innovative radiation technology to treat patients with malignant pleural mesothelioma and lung cancer.

Dr. Anastasios Dimou is a medical oncologist with a special interest in the treatment of lung cancer, malignant mesothelioma, and other thoracic malignancies, as well as melanoma. He sees patients at the Mayo Clinic in Rochester, Minnesota,

Dr. Andrea Wolf is the Director of the New York Mesothelioma Program at the Mount Sinai Health System in New York City. She specializes in surgery for pleural mesothelioma and video-assisted thoracic surgery.

Dr. Andreas Rimner is a board-certified Memorial Sloan Kettering Cancer Center radiation oncologist. Serving as Director of Thoracic Radiation Oncology Research, he specializes in caring for patients diagnosed with cancers of the chest, including non-small cell and small cell lung cancers and pleural mesothelioma. He leads a research time in conducting multiple clinical trials.

Dr. Andreas Saltos is a thoracic oncologist specializing in the treatment of lung cancer and malignant pleural mesothelioma at Moffitt Cancer Center in Tampa, Florida. He also directs all clinical research involving thoracic malignancies at the center.

Dr. Andrew Ching-Hung Chang is a thoracic surgeon at the University of Michigan’s Rogel Cancer Center. He specializes in general thoracic surgery and thoracic oncology, including minimally invasive surgical techniques for patients diagnosed with malignant pleural mesothelioma and lung cancer.

Dr. Andrew Lowy is a surgical oncologist at the University of California San Diego’s Moore’s Cancer Center in San Diego, California. He specializes in treating cancers of the GI tract, pancreas, and liver, with special interest in the management of patients with metastatic disease to the liver and peritoneum, which he treats using hyperthermic intraperitoneal chemotherapy.

Dr. Blakely is a surgical oncologist and specializes in peritoneal surface malignancies. His expertise includes the treatment of peritoneal mesothelioma and cancers that have spread to the peritoneal tissue from other areas. Dr. Blakely currently holds the position of Senior Investigator at the National Cancer Institute, where his research focuses on improving treatments for these difficult cancers. His past research earned Dr. Blakely a patent and grant for a tissue engineering application. [4]

Dr. Andrew R. Haas is an expert in interventional pulmonary and thoracic oncology at the Hospital of the University of Pennsylvania in Philadelphia. He has deep knowledge and expertise in the use of innovative procedures for the diagnosis and treatment of benign and malignant pleural diseases, including malignant pleural mesothelioma.

Dr. Anita Lyn Sabichi is a medical oncologist and researcher at the Baylor College of Medicine in Houston, Texas. Her clinical interests include the treatment of lung cancer, mesothelioma, and other malignancies.

Dr. Anne M. Traynor is a medical oncologist at University of Wisconsin Health and the Carbone Cancer Center in Madison, Wisconsin. She specializes in the treatment of patients with lung cancer.

Dr. Tsao works as an associate professor in the MD Anderson Cancer Center at the University of Texas in the Department of Thoracic and Head & Neck Medical Oncology. Her expertise is in treating patients who have both thoracic cancers and cancers of the head and neck. As a clinician and scientist, she is involved in clinical research as well as translational lab research with a focus aimed at the identification of novel therapies and the development of new strategies for treating malignant mesothelioma and aerodigestive cancers. [31]

Dr. Anne-Marie G. Sykes is a highly respected radiologist with special expertise in imaging and diagnoses of diseases of the chest. She practices at the Mayo Clinic in Rochester, Minnesota, where she collaborates with a multidisciplinary team in the care of patients with lung cancer and malignant pleural mesothelioma.

Dr. Anthony Cassano leads the thoracic surgical department at VCU Massey Comprehensive Cancer Center in Richmond, Virginia, where patients with lung cancer and malignant pleural mesothelioma can receive cutting-edge medical and surgical treatment.

Dr. Anthony R. Lanfranco specializes in interventional pulmonary procedures used in the treatment of malignant pleural mesothelioma and lung cancer. He practices at Penn Presbyterian and is a member of Penn Medicine in Philadelphia, Pennsylvania.

Dr. Kim is a thoracic surgeon whose specialties include treating lung cancer and malignant mesothelioma. He leads the thoracic surgery division at Keck Medicine of University of Southern California. His areas of expertise include minimally invasive thoracic surgery and robotic surgery.

Antoinette J. Wozniak is an internationally respected clinical researcher focused on lung cancer and malignant pleural mesothelioma at the University of Pittsburgh Medical Center and UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania.

Dr. Anton J. Bilchik is an internationally recognized surgical oncologist who practices at Providence Saint John’s Health Center and its John Wayne Cancer Institute in Santa Monica, California. He pioneered techniques to improve minimally invasive approaches for liver and pancreas cancer and has expertise in laparoscopic and robotic surgery, as well as hyperthermic intraoperative peritoneal chemotherapy (HIPEC) for peritoneal mesothelioma.

Dr. Apar Kishor Ganti is an oncologist and Professor of Internal Medicine at the University of Nebraska Medical Center. He specializes in research and patient care for lung cancer, malignant mesothelioma, and head and neck cancers.

Dr. Arek Z. Dudek is a medical oncologist and researcher at the Mayo Clinic in Rochester, Minnesota. He specializes in the development and application of innovative cancer therapies for the treatment of advanced malignancies, including lung cancer and malignant mesothelioma.

Dr. Armando Sardi is a highly respected surgical oncologist whose skill in the use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) has made him a leader in the care of patients diagnosed with malignant peritoneal mesothelioma. He practices at the Institute for Cancer Care at Mercy in Baltimore, Maryland.

Dr. Balazs Halmos is a medical oncologist and team leader of lung cancer treatment at the Montefiore Einstein Comprehensive Cancer Center in the Bronx, New York. His clinical interests include mesothelioma, thymoma, and small-cell lung cancer.

Dr. Barry C. Gibney is a surgeon at the Medical University of South Carolina and Hollings Cancer Center in Charleston, South Carolina. He specializes in lung and thoracic cancer surgery, as well as cardiothoracic surgery.

Dr. Bartley P. Griffith is a renowned cardiothoracic surgeon at the University of Maryland Medical System. As a member of the Mesothelioma and Thoracic Oncology Treatment and Research Center surgical team, his expertise in the complex surgical procedures that mesothelioma patients require is invaluable.

Dr. Bassan J. Allan is a surgical oncologist with South Florida Surgical Oncology in Ft. Myers, Florida. He is a specialist in the use of hyperthermic intraperitoneal chemotherapy, a complex surgical technique that has proven effective in improving prognosis and quality of life for patients diagnosed with peritoneal mesothelioma.

Dr. Benjamin D. Kozower is a cardiothoracic surgeon at BJC HealthCare in St. Louis, Missouri. His practice focuses on using robotic surgery to treat patients with lung cancer, esophageal cancer, and other thoracic cancers.

Dr. Benjamin Herzberg is a medical oncologist specializing in the treatment of thoracic malignancies, including malignant pleural mesothelioma. He is affiliated with Columbia University’s Herbert Irving Comprehensive Cancer Center and New York Presbyterian Hospital.

Dr. Benjamin Medina is a thoracic surgeon at RWJBarnabas Health and the Rutgers Cancer Institute of New Jersey. He specializes in procedures for patients diagnosed with lung cancer, esophageal cancer, mediastinal tumors, chest wall tumors, and malignant pleural mesothelioma.

Dr. Benjamin Wei is a thoracic and cardiothoracic surgeon at the University of Alabama and O’Neal Comprehensive Cancer Center. He specializes in robotic-assisted and video-assisted thoracic surgery for patients diagnosed with lung and esophageal cancers.

Dr. Betty C. Tong is a surgical oncologist and thoracic surgeon at the Duke Cancer Center in Durham, North Carolina. Her clinical expertise lies in the treatment of malignant pleural mesothelioma, lung cancer, and esophageal cancer. She is skilled in minimally invasive surgery.

Dr. Boris Sepesi is a thoracic surgeon board-certified in general and thoracic surgery. He practices at HealthOne Medical Center and as part of the HealthONE Physician Group in Aurora, Colorado, providing care for patients diagnosed with malignant mesothelioma, lung cancer, and other thoracic malignancies and diseases.

Dr. Bradford Perez is a radiation oncologist at the Moffitt Cancer Center in Tampa, Florida who uses innovative tools to treat patients with thoracic malignancies, including lung cancer and malignant pleural mesothelioma. Dr. Perez is particularly interested in combining state-of-the-art imaging technologies with immunotherapies and other novel protocols.

Dr. Brendon Stiles is a thoracic surgeon at Montefiore Einstein Comprehensive Cancer Center. He specializes in the use of minimally invasive surgical treatment for patients with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies.

Dr. Bret Mitchell Schipper is a surgical oncologist who practices at Hartford Hospital and Hartford HealthCare Cancer Institute in Hartford, Connecticut. He has expertise in laparoscopic and robotic surgery, as well as hyperthermic intraoperative peritoneal chemotherapy (HIPEC) for peritoneal mesothelioma.

Dr. Loggie is a physician and researcher most noted for his work in pioneering a treatment for malignant mesothelioma called heated intraperitoneal chemotherapy in the 1990s. The treatment–which is now growing to be more widely used than ever before due to its effectiveness in eradicating many types of cancers–involves a combination of hyperthermic chemotherapy medications and surgical procedures. [20]

Dr. Brian Mitzman is a thoracic surgical oncologist at the University of Utah Health and the Huntsman Cancer Institute in Salt Lake City, Utah. He specializes in robotic surgical techniques for the treatment of lung cancer, malignant pleural mesothelioma, esophageal cancer, and other thoracic malignancies.

Dr. Brian Pettiford is a thoracic surgeon who specializes in the use of minimally invasive surgical procedures to treat malignant pleural mesothelioma, lung cancer, and other thoracic and esophageal diseases. He practices at the Ochsner M.D. Anderson Cancer Center in New Orleans, Louisiana.

Dr. Bruce E. Johnson is a medical oncologist and Leader of the Lung Cancer Program for the Dana-Farber/Harvard Cancer Center in Boston. He treats patients diagnosed with small cell and non-small cell lung cancer, mesothelioma, and other thoracic malignancies.

Dr. Bruno Bastos is a highly respected medical oncologist and researcher who treats patients with a range of cancers at the Miami Cancer Institute in Miami, Florida. Dr. Bastos’ academic research and clinical interests include novel treatments for patients with mesothelioma and lung cancer.

Dr. Bryan Burt is an internationally recognized thoracic surgeon-scientist and oncologist at UCLA Health and the David Geffen School of Medicine at UCLA. He specializes in minimally invasive robotic surgery for the treatment of lung cancer and malignant pleural mesothelioma.

Dr. Bryan James Schneider is a medical oncologist at the University of Michigan’s Rogel Cancer Center in Ann Arbor. He specializes in treating patients diagnosed with lung cancer, esophageal cancer, malignant mesothelioma, thymoma, and carcinoid tumors.

Dr. Byrne Lee is a surgical oncologist at Stanford University and the Stanford Cancer Center in Palo Alto, California. As leader of the surgical team of the peritoneal surface malignancy and HIPEC program, he offers innovative surgical options for patients diagnosed with malignant peritoneal mesothelioma.

Dr. Carlos H. Chan is a surgical oncologist at University of Iowa Health Care. He specializes in treating advanced gastrointestinal and abdominal cancers, including malignant peritoneal mesothelioma.

Dr. Carrie B. Lee is a thoracic oncologist at UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. Her practice is primarily focused on treating patients with lung cancer, applying her knowledge of novel and standard-of-care chemotherapy regimens to achieve the best outcomes.

Dr. Carrie Luu is a surgical oncologist who performs cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for patients with peritoneal mesothelioma. She practices at the University of Arizona College of Medicine and Cancer Center in Tucson, Arizona.

Dr. Chad E. Denlinger is a thoracic surgeon at the Indiana University School of Medicine and Comprehensive Cancer Center in Indianapolis. His clinical interests are in minimally invasive surgical techniques for the treatment of lung cancer and other thoracic cancers.

Dr. Chad V. Pecot is a thoracic oncologist at UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in treating solid tumor malignancies including malignant pleural mesothelioma, with a particular interest in lung cancer.

Dr. Chakravarthy B. Reddy is an interventional pulmonologist at University of Utah Health and the Huntsman Cancer Institute in Salt Lake City, Utah. He works within the thoracic oncology program to diagnose, stage, and manage patients with lung cancer and malignant pleural mesothelioma.

Dr. Chao H. Huang is a medical oncologist and Director of the Lung Program at the University of Kansas Medical Center. A specialist in lung cancer, chest cancers, and head and neck cancers, he is dedicated to identifying the right treatment protocol for each patient and finding the protocol that will deliver the best possible outcome.

Dr. Charles A. Powell is a professor of medicine and chief of the Division of Pulmonary, Critical Care, and Sleep Medicine at the Icahn School of Medicine at Mount Sinai School of Medicine. His clinical and research interests are lung cancer and malignant mesothelioma.

Dr. Charles A. Staley is a surgical oncologist and Chief of the Division of Surgical Oncology at the Winship Cancer Institute at Emory University. He is an expert in the care of abdominal and gastrointestinal malignancies, including malignant peritoneal mesothelioma. He is skilled in the complex procedure known as CRS/HIPEC, or cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Dr. Charles B. Simone is a radiation oncologist at Memorial Sloan Kettering Cancer Center and the New York Proton Center in New York, New York. He specializes in the use of proton therapy to treat patients with malignant pleural mesothelioma and lung cancer.

Dr. Charles Mulligan is a thoracic surgeon at the Helen F. Graham Cancer Center at Christiana Care in Newark, Delaware. He specializes in thoracic oncology, mesothelioma, lung cancer, and esophageal cancer.

Dr. Christian Rolfo is a noted medical oncologist and world-renowned lung cancer and mesothelioma researcher at the Mount Sinai Health System in New York City. He specializes in the use of liquid biomarkers and targeted drug therapies to improve patient outcomes.

Dr. Christina Baik is a medical oncologist who specializes in thoracic, head, and neck cancers at Fred Hutchinson Cancer Center and UW Medicine in Seattle, Washington. Her practice includes caring for patients with lung cancer and malignant pleural mesothelioma.

Dr. Christine A. Ciunci is a medical oncologist who specializes in thoracic malignancies like pleural mesothelioma and lung cancers at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania.

Dr. Christine Lau is a nationally recognized thoracic surgeon who practices at the University of Maryland School of Medicine and the University of Maryland Medical Center in Baltimore, Maryland. Her specialties include lung transplantation and all aspects of thoracic surgery, including minimally invasive surgical techniques for the treatment of malignant mesothelioma and lung cancer.

Dr. Christine M. Lovly is a medical oncologist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. She is both a clinician and a scientist who is dedicated to improving outcomes for patients with lung cancer and other thoracic malignancies, including malignant pleural mesothelioma.

Dr. Christopher Aquina is a surgical oncologist at AdventHealth in Orlando, Florida. He has a special interest in the use of hyperthermic intraperitoneal chemotherapy for advanced metastatic cancers and peritoneal surface malignancies, as well as malignant peritoneal mesothelioma.

Dr. Christopher D. Scott is a thoracic surgeon at UVA Comprehensive Cancer Center and UVA Health in Charlottesville, Virginia. He specializes in minimally invasive and robotic surgical techniques for the treatment of malignant pleural mesothelioma, lung cancer, and other thoracic diseases and malignancies.

Dr. Christopher Wigfield is a thoracic surgeon at Northern Light Cardiothoracic Surgery in Bangor, Maine. Dr. Wigfield has a distinguished career highlighted by advancing innovations in robotic surgery for lung cancer and thoracic malignancies like pleural mesothelioma and lung transplantation.

Dr. Ihemelandu is a board-certified surgical oncologist who specializes in the treatment of intra-abdominal cancers, including malignant peritoneal mesothelioma. He specializes in innovative surgical techniques that include intra-operative heated chemotherapy.

Dr. Chukwuemeka Obiora is a surgical oncologist who practices at City of Hope in Atlanta, Georgia. He specializes in the use of cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal surface malignancies and peritoneal mesothelioma.

Dr. Chuong D. Hoang is a surgeon-scientist at the National Cancer Institute in Bethesda, Maryland. His clinical expertise is innovative surgical techniques for the treatment of malignant pleural mesothelioma and lung cancer, though the majority of his time is dedicated to finding laboratory-based answers to improving outcomes for these diseases.

Dr. Corey J. Langer is a highly respected medical oncologist and researcher who focuses on improving outcomes for patients with malignant pleural mesothelioma and lung cancers. He is the Director of Thoracic Oncology at Penn Health in Philadelphia, Pennsylvania.

Dr. Corey Kershaw is a physician at UT Southwestern Medical Center in Dallas, Texas. He uses his expertise in internal medicine, pulmonology, critical care, and occupational lung disease to diagnose and treat patients with mesothelioma, lung cancer, and other interstitial lung diseases.

Dr. Craig Glazer specializes in pulmonary and critical care medicine at UT Southwestern Medical Center in Dallas. His focus is the care of patients diagnosed with lung diseases caused by occupational and environmental exposure.

Dr. Craig Stevens is an internationally recognized expert in the use of radiation oncology to treat patients with malignant pleural mesothelioma and lung cancer, as well as other thoracic malignancies. He practices at Beaumont Health in Royal Oak, Michigan.

Dr. Camidge is a medical oncologist with a focus on thoracic malignancies including malignant pleural mesothelioma and lung cancer. He is actively involved in Phase 1 studies of developmental therapeutics and has been ranked among the top 1% of clinical medicine researchers internationally.

Dr. Dan Blazer is a surgical oncologist at Duke Health and the Duke Cancer Institute in Durham, North Carolina. He treats patients with malignant peritoneal mesothelioma, using a complex procedure in which tumors are removed surgically and the surgical site is bathed in a heated chemotherapy solution.

Dr. Daniel De Armond is a thoracic surgeon at UT Health San Antonio MD Anderson Cancer Center. He specializes in minimally invasive surgery for patients with lung cancer.

Dr. Daniel Labow is a fellowship-trained surgeon with a specialty in surgical oncology and an international reputation for performing hyperthermic intraperitoneal chemotherapy for patients with cancers like malignant peritoneal mesothelioma. He is the Chair of Surgery at Nuvance Health in Danbury, Connecticut.

Dr. Daniel Miller is a cardiothoracic and general surgeon who treats patients with thoracic malignancies at the Medical College of Georgia and Augusta University’s Georgia Cancer Center. He specializes in minimally invasive procedures to address the needs of those with lung cancer and malignant pleural mesothelioma.

Dr. Daniel Morgensztern is a medical oncologist at the Siteman Cancer Center. As part of the facility’s team of lung cancer specialists, he works with patients diagnosed with lung cancer, mesothelioma, and other thoracic malignancies to improve quality of life and outcomes.

Dr. Sterman is a physician specializing in critical care and pulmonology. He currently serves in several positions at New York University’s Langone Medical Center and Perlmutter Cancer Center. His positions allow him to work directly with patients, to be an educator, and to lead and direct research. His research into cancers, including gene therapy to treat mesothelioma, has gained him international recognition and the admiration and respect of both peers and patients. [28]

Dr. Dao Minh Nguyen is a thoracic surgeon, surgical oncologist, and cardiothoracic surgeon with the University of Miami Health System. He specializes in minimally invasive procedures for thoracic cancers, including malignant pleural mesothelioma and lung cancer.

Dr. Darren Bryan is a thoracic surgeon at the University of Chicago Comprehensive Cancer Center. He is part of the mesothelioma physician team. He specializes in caring for patients with lung cancer and malignant pleural mesothelioma.

Dr. David B. Nelson is a thoracic surgeon at UT Southwestern Medical Center in Dallas, Texas. He specializes in minimally invasive surgery for lung malignancies, including malignant pleural mesothelioma.

Dr. Bartlett is an expert surgical oncologist who specializes in managing complex and advanced abdominal diseases, abdominal sarcomas, gastric cancer, and liver and bile duct cancer. He serves as vice-chairman of the David C. Koch Regional Perfusion Cancer Therapy Center as well as vice-chairman of surgical oncology and gastrointestinal services at the University of Pittsburgh Medical Center. He is also the director of the University of Pittsburgh Cancer Institute’s Multidisciplinary Disease Site Clinical and Research Programs. [2]

Dr. David C. Rice is a thoracic surgeon who uses highly innovative, minimally invasive surgical techniques to treat patients diagnosed with malignant pleural mesothelioma and lung cancer. He practices at UT M.D. Anderson in Houston, Texas.

Dr. David Gerber is a lung cancer specialist at UT Southwestern Medical Center and the Harold C. Simmons Comprehensive Cancer Center in Dallas, Texas.

Dr. David Harpole Jr. is a thoracic surgeon at the Duke Cancer Center in Durham, North Carolina. He specializes in minimally invasive thoracic surgery for patients with lung cancer, esophageal cancer, and other thoracic malignancies including malignant pleural mesothelioma.

Dr. David J. Kwiatkowski is a medical and thoracic oncologist at Dana-Farber Cancer Institute in Boston. He has broad interests in all types of thoracic malignancies, including lung cancer, thymic cancer, and mesothelioma.

Dr. David Johnstone is a thoracic surgeon with the Froedtert Hospital and the Medical College of Wisconsin Clinical Cancer Center in Milwaukee, Wisconsin. He treats patients diagnosed with lung cancer, lung tumors, and other lung disorders requiring surgery, including malignant pleural mesothelioma.

Dr. Jablons studied medicine at the Albany Medical College of Union University New York, having won a preceptorship studying under Dr. Steven Rosenberg at the National Cancer Institute in his fourth year of study there. His training with Dr. Rosenberg sparked a deep interest in translational science, and Dr. Jablons currently serves as the Chief of General Thoracic Surgery, Director of the Thoracic Oncology Lab, and program leader of Thoracic Oncology at UCSF as well as being the Nan T. McEvoy Distinguished Professor of Thoracic Surgical Oncology. [15]

Dr. David P. Carbone is a thoracic oncologist at the James Cancer Hospital. In addition to treating patients with lung cancer and malignant pleural mesothelioma, he oversees thoracic oncology and translational lung cancer research there.

Dr. David Mason is an experienced thoracic surgeon who specializes in minimally invasive surgery for lung cancer, malignant mesothelioma, and other challenging conditions.

Dr. David R. Spigel is a medical oncologist who specializes in treating patients with lung cancer and other thoracic malignancies. He practices at the Sarah Cannon Research Institute in Nashville, Tennessee, where he directs the lung cancer program.

Dr. David S. Schrump is a thoracic surgeon whose expertise in treating thoracic malignancies, including malignant pleural mesothelioma and lung cancer, led to his assignment to the position of Surgical Chief of the Thoracic Surgery ranch of the National Cancer Institute’s Center for Cancer Research. He is responsible for significant discoveries leading to improvements in patient outcomes.

Dr. David Sternberg is a cardiothoracic surgeon at Karmanos Cancer Institute in Detroit, Michigan. He specializes in minimally invasive chest surgery, treating patients with esophageal cancer and lung cancer.

Dr. David Tom Cooke is a national leader in robotic thoracic surgery. He specializes in the surgical treatment of malignant and benign lung conditions including lung cancer and malignant mesothelioma. He has a special interest in patient-centered outcomes research, cancer clinical trials, and breaking down racial barriers to better cancer care.

Dr. Deborah S. Bruno is a medical oncologist and researcher at University Hospitals Seidman Cancer Center. She specializes in innovative treatment of patients with malignant pleural mesothelioma, lung cancer, and other thoracic malignancies.

Dr. Dennis Wigle is a thoracic surgeon and researcher dedicated to understanding and treating lung cancer and other thoracic malignancies, including malignant pleural mesothelioma. He is Chair of the Division of Thoracic Surgery at the Mayo Clinic in Rochester, Minnesota. His areas of focus include robotic and minimally invasive surgery.

Dr. Diane Tseng is a medical oncologist and researcher who specializes in treating patients with lung cancer and malignant pleural mesothelioma at the Fred Hutchinson Cancer Center in Seattle, Washington.

Dr. Dipesh Uprety is a thoracic oncologist who is part of the Multidisciplinary Thoracic Oncology Program at Karmanos Cancer Institute in Detroit, Michigan. He sees patients diagnosed with lung cancer, thymic cancers, and malignant pleural mesothelioma.

Dr. Divya Sood is a surgical oncologist specializing in the treatment of malignant peritoneal mesothelioma and other abdominal cancers at the Knight Cancer Institute.

Dr. Dong Shin is a medical oncologist with a high level of expertise in treating head and neck cancer, thyroid cancer, pleural mesothelioma, and thymoma. He practices with the Emory Healthcare Network and the Winship Cancer Institute of Emory University.

Dr. Douglas Allen Arenberg is a pulmonologist and critical care physician with the University of Michigan Health, He specializes in diagnosing, staging, preventing, and treating patients with lung cancer.

Dr. Ankit Bharat is chief of thoracic surgery at Northwestern Medicine and the Lurie Cancer Center. He specializes in treating patients with lung cancer and other difficult-to-treat thoracic malignancies, including malignant pleural mesothelioma.

Dr. Ian Christopher Bostock Rosenzweig is a thoracic surgeon at the Hollings Cancer Center and MUSC Health in Charleston, South Carolina. He provides advanced surgical care for patients with lung and esophageal cancer, mesothelioma, mediastinal and chest wall tumors, and benign diseases.

Dr. Kathryn Engelhardt is a thoracic surgeon with expertise in cancer care, lung transplantation, and robotic surgery. She practices at the Hollings Cancer Center and MUSC Health in Charleston, South Carolina.

Dr. Dwight Owen is a thoracic oncologist at Ohio State University Comprehensive Cancer Center and The James Cancer Hospital in Columbus, Ohio. Dr. Owen specializes in treating patients with thoracic malignancies, including lung cancer, malignant pleural mesothelioma, and thymic cancers.

Dr. Edmund K. Moon is a board-certified pulmonologist and cancer researcher who is dedicated to scientific investigation that will improve outcomes for patients diagnosed with malignant pleural mesothelioma, lung cancer, and other advanced solid tumors of the thoracic cavity.

Dr. Edward A. Levine is a surgical oncologist and professor of surgery at Wake Forest Medical Center and Cancer Center. Dr. Levine has clinical and research expertise in the use of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma.

Dr. Elbert Kuo is a nationally renowned thoracic surgeon on staff at Banner MD Anderson Cancer Center in Gilbert, Arizona. He has expertise in minimally invasive and robotic surgery for lung cancer, esophageal cancer, and other thoracic malignancies, including malignant pleural mesothelioma.

Dr. Elizabeth M. Gleeson is a surgical oncologist at the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. She performs surgery for peritoneal diseases including malignant peritoneal mesothelioma and is skilled in HIPEC (hyperthermic Intraperitoneal Chemotherapy).

Dr. Wakeam is a thoracic surgeon and assistant professor at the University of Michigan. He trains surgeons and works with patients in the Michigan Medicine Thoracic Surgery Clinic, Taubman Center, and Michigan Medical Procedures Unit. He is a specialist in minimally invasive thoracic surgery with a focus on oncology and lung transplants. Dr. Wakeam is a part of the University of Michigan Lung Transplant Program. His research has focused on lung transplants and the treatment of thoracic cancers, including pleural mesothelioma. Dr. Wakeam has been instrumental in bringing the SMART protocol for mesothelioma treatment to patients in Michigan. [34]

Dr. Emily DuComb is a pulmonologist and critical care medicine specialist at the University of Michigan’s Rogel Cancer Center and University of Michigan Health. Her professional focus is on caring for patients with pleural disorders, including malignant pleural mesothelioma.

Dr. Epameinondas Dogeas is a surgical oncologist who practices at Banner MD Anderson Cancer Center in Phoenix, Arizona. His clinical skills include cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma.

Dr. Eric Haura is a thoracic oncologist and the Director of the Moffitt Lung Cancer Center of Excellence in Florida. He is an expert in the management of lung cancer and a world leader in researching novel approaches to its treatment.

Dr. Lambright is a thoracic surgeon with special interests in pulmonary malignancies, lung transplantation, lung failure surgery, and a variety of minimally invasive techniques. He serves as Associate Professor of Thoracic Surgery and Surgical Director of Lung Transplant in the Department of Thoracic Surgery, as well as Chief of Thoracic Surgery at the Veterans Affairs Medical Center in Nashville.

Dr. Eric Luk is a board-certified medical oncologist at the Messino Cancer Center in Asheville, North Carolina. He specializes in treating patients with aggressive thoracic cancers, including malignant pleural mesothelioma. He also treats patients with head and neck cancers.

Dr. Vallieres studied medicine at Quebec’s Université Laval and was a resident at the University of Toronto. He later completed a fellowship in Bordeaux, France under the tutelage of Professor Louis Couraud. Dr. Vallieres currently serves as surgical director of the Lung Cancer Program at Seattle’s Swedish Medical Center, focusing his research on surgical treatment of lung cancer and induction chemotherapy. He specializes in malignant mesothelioma, chest wall tumors, hyperhidrosis, bronchoscopy, and esophageal achalasia. [33]

Dr. Erik Lewis is a thoracic surgeon at the University of Nebraska Medical Center and the Fred and Pamela Buffett Cancer Center. He treats patients with lung and esophageal cancers and other thoracic malignancies, as well as those with benign thoracic conditions.

Dr. Erin P. Ward is a surgical oncologist who specializes in treating peritoneal surface malignancies, including malignant peritoneal mesothelioma, at University of Utah Health and the Huntsman Cancer Institute in Salt Lake City, Utah.

Dr. Estelamari Rodriguez is a medical oncologist at the University of Miami Sylvester Comprehensive Cancer Center with a special interest in the early detection and treatment of malignant mesothelioma and lung cancer.

Dr. Eugene Choi is a surgical oncologist at the Baylor College of Medicine and the Dan L. Duncan Comprehensive Cancer Center in Houston, Texas. He specializes in the use of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma.

Dr. Evan S. K. Ong is a surgical oncologist at the Swedish Medical Center in Seattle, Washington. His clinical focus is on gastrointestinal cancers, including malignant peritoneal mesothelioma.

Dr. Evan Osmundson is a radiation oncologist at Vanderbilt University Medical Center in Nashville, Tennessee. He specializes in the treatment of patients diagnosed with pleural mesothelioma, lung cancer, and other thoracic malignancies.

Dr. Evan S. K. Ong is a surgical oncologist at Swedish Health in Seattle, Washington. He specializes in the use of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with gastrointestinal cancers, including malignant peritoneal mesothelioma.

Dr. Fabian Johnston is a surgical oncologist and leader in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and other surgical techniques for the treatment of malignant peritoneal mesothelioma, colorectal cancer, and other gastrointestinal tumors. Dr. Johnston is the Division Chief of Gastrointestinal Oncology at Johns Hopkins Medicine in Baltimore, Maryland.

Dr. Fadi Dahdaleh is a surgical oncologist with Edward-Elmhurst Health in Chicago, Illinois, He has expertise in the treatment of complex, advanced malignancies, and uses cytoreductive surgery with hyperthermic intraperitoneal chemotherapy to treat malignant peritoneal mesothelioma.

Dr. Fadi S. Braiteh is a medical oncologist at the Comprehensive Cancer Centers of Nevada in Las Vegas. His clinical and research focus is on gastrointestinal cancers and thoracic and breast malignancies. His practice includes care of patients diagnosed with malignant pleural mesothelioma and lung cancer.

Dr. Farhood Farjah is a thoracic surgeon specializing in minimally invasive procedures for lung cancer, mesothelioma, and other malignancies of the chest at the University of Washington and Fred Hutchinson Cancer Center in Seattle, Washington.

Dr. Farid Gharagozloo is a cardiothoracic surgeon and pioneer in robotic surgery for malignant pleural mesothelioma. He was the first in the world to perform a robot-assisted extrapleural pneumonectomy. He is also Professor of Surgery at the University of Central Florida.

Dr. Fatemeh Ardeshir-Larijani is a medical oncologist at the Winship Cancer Institute of Emory Medicine in Atlanta, Georgia. She specializes in the care of patients with thoracic malignancies, including lung cancer and malignant pleural mesothelioma.

Dr. Fawi F. Abu Rous is a medical oncologist specializing in thoracic malignancies, including lung cancer and malignant pleural mesothelioma. He is an integral part of the multidisciplinary mesothelioma team at Henry Ford Health in Detroit Michigan.

Dr. Federico Tozzi is a surgical oncologist at UT Health San Antonio with a deep interest in cancer care. He performs cytoreductive surgery with hyperthermic intraperitoneal mesothelioma for patients diagnosed with peritoneal malignancies, including malignant peritoneal mesothelioma.

Dr. Fereidoun Abtin is a thoracic interventional radiologist specializing in the treatment of lung cancer and malignant pleural mesothelioma at UCLA Health in Santa Monica, California. He is a pioneer in the use of cryoablation and other innovative techniques for the removal of pulmonary tumors.

Dr. Francis C. Nichols, III is a cardiothoracic and general surgeon whose practice includes the treatment of patients with thoracic malignancies including lung cancer and malignant pleural mesothelioma. He is a consultant at the Mayo Clinic in Rochester, Minnesota.

Dr. Francis D. Sheski is a pulmonologist at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center in Indianapolis, Indiana. He is dedicated to discovering alternative treatments for lung cancers and other thoracic conditions that will offer faster recovery, less pain, and better outcomes.

Dr. Frank Detterbeck is the Chief of Thoracic Surgery at Yale Cancer Center. He specializes in the treatment of thoracic malignancies including lung cancer and malignant pleural mesothelioma, largely by performing minimally invasive surgeries.

Frank V. Fossella, MD is a medical oncologist who specializes in treating patients with thoracic malignancies like lung cancer and malignant pleural mesothelioma. He practices at the University of Texas MD Anderson Cancer Center in Houston, Texas. He has a distinguished record of conducting innovative research to improve treatment efficacy and reduce adverse effects.

Dr. Frederic J. Kaye is an oncologist and cancer specialist with a focus on thoracic malignancies. He has been treating patients diagnosed with malignant mesothelioma and lung cancer for over four decades and has made significant contributions to the understanding of lung cancer tumor biology and targeted therapy for the treatment of these challenging illnesses.

Dr. G. Alexander Patterson is a Professor of Surgery and thoracic surgeon at Washington University School of Medicine at the Siteman Cancer Center in St. Louis, Missouri. He specializes in treating patients with lung cancer and esophageal cancer, as well as other thoracic malignancies.

Dr. Garrett M. Nash is a surgical oncologist at Memorial Sloan Kettering Cancer Center in New York. His specialties include minimally invasive techniques for the management of malignant peritoneal mesothelioma.

Dr. Gary M. Hochheiser is a thoracic surgeon and oncologist who sees patients at the Maine Medical Center in Portland, Maine. He specializes in all types of thoracic diseases and malignancies, with a special focus on esophageal cancer, lung cancer, and malignant pleural mesothelioma.

Dr. Gaurav Marwaha is a radiation oncologist at RUSH University Medical Center in Chicago, Illinois. He specializes in the treatment of patients with lung cancer, mediastinal/chest tumors, mesothelioma, and esophageal cancer.

Dr. George Salti is a surgical oncologist and specialist in the complex surgical treatment called cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, or HIPEC for the treatment of malignant peritoneal mesothelioma.

Dr. George Simon is a medical oncologist at the Moffitt Cancer Center in Tampa Florida who is widely recognized for his leadership in drug development and thoracic malignancies, including pleural mesothelioma and lung cancer.

Dr. Gerard Silvestri is a pulmonologist and critical care physician at the Hollings Cancer Center and MUSC Health. He specializes in treating patients with lung and thoracic cancers, including malignant pleural mesothelioma.

Dr. Gerard Abood is a surgical oncologist with Loyola Medicine in Maywood, Illinois. His skills include the combination procedure known as CRS with HIPEC, or cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, for the treatment of malignant peritoneal mesothelioma.

Dr. Giorgos C. Karakousis is a surgical oncologist and expert in the use of cytoreductive surgery with HIPEC at Penn Health and the Hospital of the University of Pennsylvania. His skill is applied to the treatment of patients with malignant peritoneal mesothelioma.

Dr. Giuseppe Giaccone is an internationally recognized expert in lung cancer and other thoracic malignancies, including malignant mesothelioma. He has introduced many cutting edge technologies to patient care.

Dr. Gregory Otterson is a thoracic oncologist at the James Cancer Hospital in Columbus, Ohio. He specializes in the care and treatment of patients with thoracic malignancies, including adenocarcinoma, mesothelioma, and thymic cancers.

Dr. Gregory Michael Lubiniecki is a medical oncologist and clinical researcher who both sees patients at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, and leads clinical cancer research design at Merck & Company. He specializes in treating patients diagnosed with lung cancer and mesothelioma.

Dr. Gregory Peter Kalemkerian is an internist, medical oncologist, and clinical researcher at the University of Michigan’s Rogel Cancer Center. He treats people diagnosed with lung cancer, thymic tumors, and mesothelioma.

Dr. H. Richard Alexander, Jr. is a surgical oncologist and researcher at Rutgers Cancer Institute of New Jersey. He is also the System Director of Surgical Oncology at RWJBarnabas Health. His clinical and research focus is gastrointestinal cancer, and particularly peritoneal mesothelioma.

Dr. Harmik J. Soukiasian is a thoracic surgeon and expert in minimally invasive robotic thoracic surgery at Cedars-Sinai Health System. He applies his skill and knowledge to the care of patients diagnosed with lung cancer, mesothelioma, esophageal cancer, and other thoracic malignancies and diseases.

Dr. Harveshp Mogal is a surgical oncologist at UW Medicine and the Fred Hutchinson Cancer Center in Seattle, Washington. His expertise in the use of hyperthermic intraperitoneal chemotherapy benefits patients diagnosed with malignant peritoneal chemotherapy.

Dr. Pass is the chief of thoracic surgery at NYU’s Langone Medical Center where he was instrumental in creating a fellowship in thoracic surgery. Also a researcher focused on mesothelioma, he leads the Early Detection Research Network Biomarker Discovery Laboratory for Mesothelioma and the Mesothelioma Pathogenesis Program Project, funded by the National Cancer Institute. In his research, Dr. Pass has helped to develop the use of photodynamic therapy, an innovative cancer treatment that uses light-sensitive drugs to target tumors. [21]

Dr. Hassan A. Khalil is a thoracic surgeon whose clinical focus is on the care of patients with lung cancer, malignant mesothelioma, and other thoracic and foregut diseases. He practices at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston.

Dr. Hatem Halabi is a surgical oncologist with the City of Hope in Chicago, He specializes in complex surgical procedures, including cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant peritoneal mesothelioma and other advanced abdominal cancers.

Dr. Heather Wakelee is a thoracic medical oncologist specializing in the treatment of lung cancer, mesothelioma, and thymomas. She is actively involved in both patient care and research into finding better treatments for pleural cancers. In addition to her role as Deputy Director of the Stanford Cancer Institute and Division Chief of Medical Oncology, she is also a leader in many national and international organizations related to lung cancer and mesothelioma.

Dr. Kindler’s medical specialty is in treating several forms of cancer, such as gastrointestinal stromal tumors, pancreatic cancer, and mesothelioma. She is also actively involved in research endeavors that focus on investigating new agents for treating these cancer types, and designing and leading various clinical trials for patients who suffer from these illnesses. [16]

Dr. Helen J. Ross is a medical oncologist and clinical researcher specializing in thoracic malignancies at RUSH University Cancer Center in Chicago, Illinois. She sees patients diagnosed with malignant pleural mesothelioma, lung cancer, and other malignancies affecting the chest.

Dr. Henning Gaissert is a thoracic surgeon who treats patients with lung cancer and malignant pleural mesothelioma at Massachusetts General Hospital in Boston and the Newton-Wellesley Hospital in Newton, Massachusetts. He is widely recognized as an expert in thoracic malignancies.

Dr. Hirva Mamdani is a thoracic medical oncologist and leader of the Thoracic Oncology Multidisciplinary Team at Karmanos Cancer Institute in Detroit. Her specialty is the diagnosis and treatment of patients with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies.

Dr. Batra is a board-certified Interventional Pulmonologist at the University of Alabama at Birmingham and director of the UAB Interventional Pulmonology and Pleural Disease Program. His practice focuses on the detection and treatment of pleural diseases, including malignant pleural mesothelioma.

Dr. Hossein Borghaei is a medical oncologist at Fox Chase Cancer Center in Philadelphia who leverages novel treatments and immunotherapy as well as more traditional protocols to treat patients with lung cancer, malignant mesothelioma, and other thoracic malignancies.

Dr. Hsienchang Chiu is an interventional pulmonologist at UT Southwestern Medical Center in Dallas, Texas, where he provides expertise in caring for patients with complications of malignant pleural mesothelioma and lung cancer.

Dr. Hugh Auchincloss treats patients with malignant pleural mesothelioma, lung cancer, and other thoracic diseases at the Massachusetts General Hospital in Boston. He is skilled in the use of minimally invasive and robotic surgical techniques.

Dr. Igor Brichkov is a thoracic surgeon and oncologist at Maimonides Medical Center in New York. He specializes in minimally invasive techniques to approach complicated thoracic problems, including lung cancer and malignant pleural mesothelioma.

Dr. J. Matthew Reinersman is a thoracic oncologist at Oklahoma University Health’s Stephenson Cancer Center. He treats all types of thoracic malignancies, including lung cancer, esophageal cancer, and malignant pleural mesothelioma.

Dr. Jack A. Elias cares for patients with a wide variety of lung ailments and injuries. He is a prolific researcher and runs an NIH-funded laboratory focusing on the cell and molecular biology of lung injury and repair. He is working to develop new drugs to treat lung cancer and other pleural injuries.

Dr. Jacques Fontaine is a surgeon and Montreal native of Lebanese descent, board-certified by both the American Board of Surgery and the American Board of Thoracic Surgery. As well as being the lead thoracic surgeon at the Moffitt Cancer Center’s Mesothelioma Research and Treatment Center, he also teaches at the University of South Florida as an associate professor of surgery. Dr. Fontaine is also a Fellow at both the Royal College of Surgeons of Canada and the American College of Surgeons.

Dr. James Cusack is a gastrointestinal surgeon and Director of the Peritoneal Surface Malignancy Program at the Massachusetts General Hospital in Boston, Massachusetts. He leads the hospital’s surgical team that performs cytoreductive surgery with hyperthermic intraperitoneal chemotherapy to treat patients with malignant peritoneal mesothelioma.

Dr. James D. Luketich is a leading thoracic surgeon at the University of Pittsburgh School of Medicine, where he uses a multi-modality approach to treat patients diagnosed with malignant mesothelioma, lung cancer, and other thoracic malignancies.

Dr. James D. Maloney is a thoracic surgeon at the University of Wisconsin and the Carbone Comprehensive Cancer Center, where he specializes in treating patients with lung cancer. Dr. Maloney is also active in treating veterans with lung disease.

Dr. James E. Spellman Jr. is a surgical oncologist who practices at Beebe Healthcare in Lewes, Delaware. He is a pioneer in the use of hyperthermic intraperitoneal chemotherapy, a complex surgical treatment that provides improved outcomes for patients with malignant peritoneal mesothelioma, ovarian cancer, and other malignancies.

Dr. Pingpank is a surgical oncologist specializing in cancers of the gastrointestinal tract and peritoneum. He is an associate professor and surgeon at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center. Among his areas of specialty, research, and treatment expertise is the care of patients with peritoneal mesothelioma. He has contributed to the development of HIPEC, one of the most successful treatment strategies for peritoneal mesothelioma. He is one of few specialists offering this kind of treatment, which includes surgery and direct chemotherapy. [22]

Dr. James M. Donahue is the section chief of thoracic surgery at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham. His areas of interest include lung and esophageal cancer, malignant pleural effusions, and chest wall surgery.

Dr. Jamil Khatri is a medical oncologist who specializes in the care of patients diagnosed with thoracic malignancies including lung cancer and malignant pleural mesothelioma.

Dr. Jared Weiss is a thoracic oncologist at the UNC Lineberger Comprehensive Cancer Center, where he specializes in the use of immunotherapy for the treatment of lung cancer and malignant pleural mesothelioma.

Dr. Jason Foster is a surgeon at the University of Nebraska Medical Center who specializes in surgery for oncologic conditions of the gastrointestinal tract and peritoneal cavity, including malignant peritoneal mesothelioma.

Dr. Jason Shaw is a thoracic surgeon at Maimonides Health in Brooklyn, New York. He specializes in treating patients with lung and thoracic cancer, including malignant pleural mesothelioma.

Dr. Jay M. Lee is a thoracic surgical oncologist who is internationally recognized for his clinical, academic, and research work on new drug development in lung cancer and other thoracic malignancies, including malignant pleural mesothelioma. He is the Surgical Director of the Thoracic Oncology Program at UCLA Health in Los Angeles.

Dr. Jeffrey Clarke is a medical oncologist at the Duke Cancer Center in Durham, North Carolina. He specializes in treating patients with malignant pleural mesothelioma and lung cancer.

Dr. Jeffrey Sutton is a surgical oncologist at Hollings Cancer Center and the Medical University of South Carolina in Charleston. He has expertise in cytoreduction and heated intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma.

Dr. Jeffrey Velotta is a thoracic surgeon at Kaiser Permanente Northern California in Oakland. He specializes in minimally invasive surgery for lung cancer and malignant pleural mesothelioma.

Dr. Jennifer L. Gnerlich is a surgical oncologist who specializes in the use of hyperthermic intraperitoneal chemotherapy, a complex surgical procedure that has proven effective in the treatment of malignant peritoneal mesothelioma. She practices at Lexington Medical Center in West Columbia, South Carolina.

Dr. Jennifer W. Carlisle is a medical oncologist at Emory University Hospital. She specializes in the treatment of patients diagnosed with malignant pleural mesothelioma, lung cancer, and thymic malignancies and is an active researcher at Winship Cancer Institute.

Dr. Jeremiah Deneve is a surgical oncologist at UNC Health and the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He specializes in complex surgical oncology care, particularly the treatment of patients with peritoneal surface malignancies including malignant peritoneal mesothelioma.

Dr. Jeremy Paul Cetnar is a medical oncologist at the Knight Cancer Institute and OHSU School of Medicine in Portland, Oregon. He specializes in treating a variety of cancers and is part of the institute’s lung cancer team.

Dr. Jess Schwartz is a thoracic surgeon at the Stephenson Cancer Center in Oklahoma City, Oklahoma. He specializes in treating patients with lung cancer and thoracic malignancies including malignant pleural mesothelioma.

Dr. Jessica Donington is a Professor of Surgery and Chief of the Thoracic Surgery section mi the Department of Surgery at the University of Chicago Comprehensive Cancer Center. She specializes in using multimodality therapies to treat locally advanced lung cancer, malignant pleural mesothelioma, and other thoracic malignancies.

Dr. Jesus Esquivel is a general and oncologic surgeon at Beebe Healthcare in Lewes, Delaware. He specializes in the use of cytoreductive surgery with hyperthermic intraperitoneal mesothelioma for malignancies including peritoneal mesothelioma, appendiceal cancer, and ovarian cancer.

Dr. Jhanelle Gray is a renowned thoracic medical oncologist and clinical investigator whose practice and research at the Moffitt Cancer Center have greatly influenced the standard of care for lung cancer.

Dr. Joel Baumgartner is a surgical oncologist and expert in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy at UC San Diego and its Moore Comprehensive Cancer Center.

Dr. Joel Neal is a thoracic medical oncologist at Stanford Cancer Institute in Palo Alto, California, where he treats patients diagnosed with malignant pleural mesothelioma and lung cancer using traditional treatment protocols, immunotherapy, and targeted therapies.

Dr. John Ammori is a surgical oncologist at the Seidman Cancer Center and University Hospitals in Cleveland, Ohio. He specializes in treating patients using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, a complex procedure that provides improved outcomes for patients with malignant peritoneal mesothelioma.

Dr. John A. Chabot has achieved expertise in the surgical treatment of both abdominal mesothelioma and pancreatic cancer with almost thirty years of medical experience. He is the head of the Division of Gastrointestinal and Endocrine Surgery at the New York Presbyterian Hospital in Manhattan as well as the executive director of the Pancreas Center there. Dr. Chabot is not only a practitioner but a teacher, as he serves as the David V. Habif Professor of Clinical Surgery at the College of Physicians and Surgeons at Columbia University. [7]

Dr. John D. Abad is a surgical oncologist with expertise in the use of complex surgical procedures for the treatment of advanced cancers like malignant peritoneal mesothelioma. He practices at Northwestern Medicine in Chicago, Illinois.

Dr. John D. Mitchell is a thoracic surgeon at the University of Colorado Cancer Center. His primary clinical and research interests are in the surgical treatment of lung cancers, including malignant pleural mesothelioma, esophageal surgery, and lung transplantation.

Dr. John DeRosimo is a thoracic surgeon at the Miami Cancer Institute at Baptist Health South Florida. He specializes in treating patients with malignant and benign lung and esophageal diseases, as well as with malignant pleural mesothelioma.

Dr. John Federico is a board-certified thoracic surgeon with expertise in complex surgery of the lung and chest, including robotic thoracic techniques for the treatment of lung cancer and thoracic malignancies including pleural mesothelioma. He practices in Portsmouth, New Hampshire at Portsmouth Regional Hospital and as part of Coastal Cardiothoracic and Vascular Surgery.

Dr. John M. Kane is a surgical oncologist at the Roswell Park Comprehensive Cancer Center in Buffalo, New York who plays a significant role in treating patients with malignant peritoneal mesothelioma. Dr. Kane developed the center’s HIPEC program.

Dr. John R. Roberts is a thoracic surgeon who practices at the Lynn Cancer Institute in Boca Raton, Florida. His clinical expertise is in using minimally invasive surgical techniques to treat patients diagnosed with lung cancer and thoracic malignancies.

Dr. John Waters is a thoracic surgeon at UT Southwestern Medical Center in Dallas, Texas. Dr. Waters is a specialist in non-cardiac thoracic surgery, with expertise in minimally invasive and robotic surgical techniques for malignant pleural mesothelioma and lung cancer.

Dr. John Wrangle is a thoracic medical oncologist and researcher who uses immunotherapy to treat patients with cancers of the chest, including non-small cell and small cell lung cancer and malignant pleural mesothelioma.

Dr. Greer is board certified in General Surgery and Surgical Oncology. He is an expert in treating gastrointestinal cancers, including peritoneal mesothelioma, using cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). His research interests include HIPEC, peritoneal surface malignance, and immunotherapy in solid tumors.

Dr. Jonathan C. Nesbitt is a thoracic surgeon at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. He manages thoracic diseases including lung and esophageal cancer and pleural diseases including malignant pleural mesothelioma.

Dr. Jonathan D’Cunha is a noted cardiothoracic surgeon whose specialty is surgical management of lung cancer, pleural mesothelioma, and other thoracic malignancies. He practices at the Mayo Clinic in Phoenix, Arizona, where he is a member of the Lung Cancer Program.

Dr. Jonathan Dowell specializes in treating patients with thoracic malignancies, including malignant pleural mesothelioma, and non-small and small cell lung cancer. He sees patients at the UT Southwestern Medical Center in Dallas, Texas, as well as the Dallas VA Medical Center.

Dr. Jonathan Thompson is a medical oncologist who provides specialized care for patients diagnosed with malignant pleural mesothelioma, lung cancers, thymomas, and thymic tumors at the Froedtert Hospital Cancer Center of the Medical College of Wisconsin in Milwaukee.

Dr. Riess is a thoracic oncologist who is board-certified in Oncology, Internal Medicine, and Hematology. As medical director of the U.C. Davis Comprehensive Cancer Center’s Thoracic Oncology Program, he leads a multidisciplinary team dedicated to the treatment of malignant mesothelioma, lung cancer, and other thoracic cancers, as well as researchers seeking prevention strategies and new diagnostic and therapeutic approaches.

Dr. Jordan D. Miller is a thoracic surgeon at University of Kentucky Health Care. As a member of the lung and thoracic cancer team at UK Health’s Markey Cancer Center, he provides high-quality care for patients with conditions including malignant mesothelioma, esophageal cancer, and lung cancer.

Dr. Jose Luis De Cardenas is an interventional pulmonologist at the Rogel Cancer Center and University of Michigan Health in Ann Arbor. His focus is on caring for patients with lung cancer and other thoracic and pleural malignancies, including malignant pleural mesothelioma.

Dr. Friedberg eceived his undergraduate education at the University of Pennsylvania and completed his medical degree at Harvard Medical School. He obtained his training in general surgery from Massachusetts General Hospital and is a board-certified general surgeon and thoracic surgeon, having attained his specialization at the Brigham and Women’s Hospital and Harvard Medical School. Dr. Friedberg currently serves as the Thoracic Surgeon-in-Chief of Temple University Health System and Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. [13]

Dr. Joseph Kim is the Chief of Surgical Oncology at the UK Markey Cancer Center in Lexington, Kentucky. His clinical interests include robotic surgery, and he is skilled in performing the complex procedure known as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with malignant peritoneal mesothelioma.

Dr. Joseph Skitzki is a surgical oncologist at Roswell Park Comprehensive Cancer Center in Buffalo, New York. He is skilled in treating patients with malignant peritoneal mesothelioma using cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy.

Dr. Joseph Treat is a medical oncologist who exclusively sees patients with malignant pleural mesothelioma and lung cancer. He practices at Fox Chase Cancer Center in Philadelphia.

Dr. Joshua R. Sonett is a renowned thoracic surgeon who leads his team at Columbia Surgery in New York to breakthrough techniques in the treatment of lung cancer, esophageal cancer, and pleural mesothelioma. He is also an innovator in the field of organ transplantation.

Dr. Joshua Winer is a surgical oncologist and specialist in performing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma. He practices at Emory’s Winship Cancer Institute in Atlanta, Georgia.

Dr. Jula Veerapong is a board-certified surgical oncologist and Associate Professor of Surgery at Moores Cancer Center at the University of California, San Diego. He specializes in treating peritoneal surface malignancies and is an expert in performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedures for the treatment of peritoneal mesothelioma.

Dr. Jules Lin is a thoracic and surgical critical care surgeon at the University of Michigan and Rogel Cancer Center in Ann Arbor. His areas of practice include robotic surgery and minimally invasive surgery for lung cancer, esophageal cancer, and malignant pleural mesothelioma.

Dr. Brahmer is a clinical leader in the treatment of lung cancer and mesothelioma. Her research and clinical practice focus on the development of new therapies for the treatment and prevention of lung cancer and malignant mesothelioma. In her role as Professor of Oncology and Co-Director of the Upper Aerodigestive Department within the Bloomberg-Kimmel Institute for Cancer Immunotherapy, she leads a multidisciplinary team treating patients with thoracic malignancies.

Dr. Jun Zhang is a medcal oncologist and researcher specializing in lung cancer and other thoracic malignancies at KU Medical Center in Kansas City, Kansas.

Dr. Jyoti D. Patel oversees all lung cancer clinical and research activities at Northwestern University’s Robert H. Lurie Comprehensive Cancer Center. She has dedicated her professional career to improving the lives of those with lung cancer and other thoracic malignancies.

Dr. K. Adam Lee is a thoracic surgeon at the Jupiter Medical Center in Jupiter, Florida, He is an expert in the use of robotic-assisted surgery for the treatment of lung cancer and pleural mesothelioma.

Dr. K. Eric Sommers is a thoracic surgeon and leader in the use of robotic and video-assisted thoracic surgical techniques for the treatment of malignant pleural mesothelioma and lung cancer at Tampa General Hospital in Tampa, Florida.

Dr. Kai He is a medical oncologist and professor of medicine at the Ohio State University’s James Cancer Hospital. Dr. He specializes in the personalized care of patients with thoracic malignancies, including lung cancer, malignant pleural mesothelioma, and thymic carcinoma.

Dr. Kalpaj R. Parekh is a cardiothoracic surgeon at the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center. In addition to his groundbreaking work in lung transplantation, he is also engaged in caring for patients with lung and esophageal cancers.

Dr. Kamran Idrees is Director of the Peritoneal Surface Malignancy Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. He provides state-of-the-art treatment for patients diagnosed with malignant peritoneal mesothelioma.

Dr. Katherine A. Scilla is a medical oncologist at the University of Maryland’s Greenebaum Comprehensive Cancer Center. She specializes in treating patients with malignant pleural mesothelioma and lung cancer.

Dr. Keisuke Shirai is a medical oncologist and palliative care specialist at the Dartmouth Hitchcock Norris Cotton Cancer Center in Lebanon, New Hampshire. He uses state-of-the-art therapies to treat patients diagnosed with malignant pleural mesothelioma, lung cancer, melanoma, and skin cancer.

Dr. Cengel is a radiation oncologist and Executive Director of Penn Medicine’s Mesothelioma and Pleural Diseases Program. He treats malignant pleural mesothelioma and lung cancer, as well as other cancers. Dr. Cengel is a leading expert on the use of proton therapy and is leading research on the use of photodynamic therapy on patients undergoing lung-sparing pleurectomy/decortication surgery.

Dr. Keith D. Eaton is a medical oncologist who specializes in thoracic, head, and neck cancers at Fred Hutchinson Cancer Center and UW Medicine in Seattle, Washington. His practice includes caring for patients with lung cancer and malignant pleural mesothelioma.

Dr. Kemp Kernstine is a thoracic surgeon at the UT Southwestern Medical Center in Dallas, Texas. His skill in treating lung cancer and malignant pleural mesothelioma has received both national and international recognition.

Dr. Kenneth Rosenzweig is a radiation oncologist and Chairman of the Department of Radiation Oncology at Mount Sinai’s Icahn School of Medicine. He specializes in using state-of-the-art technology to treat malignant pleural mesothelioma, lung cancer, and other thoracic malignancies.

Dr. Kevin Becker is a medical oncologist specializing in lung cancer and thoracic malignancies at Maimonides Medical Center in Brooklyn, New York.

Dr. Kevin El-Hayek is a surgeon who specializes in minimally invasive procedures for gastrointestinal diseases at MetroHealth in Cleveland, Ohio. Among his many areas of expertise, Dr. El-Hayek treats patients diagnosed with malignant peritoneal mesothelioma using cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, a complex surgical procedure that can dramatically improve patient outcomes.

Dr. Kevin Roggin is a surgical oncologist specializing in treating complex upper gastrointestinal tract cancers at the Hollings Cancer Center and Medical University of South Carolina in Charleston. He is an expert in robotic surgery and the HIPEC procedure for patients with malignant peritoneal mesothelioma.

Dr. Kiran Hari Lagisetty is a thoracic surgeon and oncologist at the University of Michigan’s Rogel Cancer Center. His particular focus is on minimally invasive approaches to thoracic malignancies including lung cancer and malignant pleural mesothelioma.

Dr. Kiran Turaga is a surgical oncologist who specializes in the use of heated chemotherapy (HIPEC) for cancers, including malignant peritoneal mesothelioma. He specializes in treating cancers and advanced tumors that are difficult to treat using traditional approaches, including malignant peritoneal mesothelioma.

Dr. Konstantin Dragnev is a medical oncologist, professor of medicine, and researcher at the Dartmouth Cancer Center and Geisel School of Medicine in Lebanon, New Hampshire. His work is focused on lung cancer, mesothelioma, and esophageal cancer.

Dr. Konstantinos Arnaoutakis is a medical oncologist specializing in the care of patients diagnosed with lung cancer and malignant mesothelioma, as well as head and neck cancers and genitourinary cancers. He sees patients at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences.

Dr. Konstantinos Chouliaras is a surgical oncologist with Baptist MD Anderson Cancer Physicians, practicing in Jacksonville, Florida. He specializes in minimally invasive surgical techniques for the treatment of advanced cancers and uses hyperthermic intraperitoneal chemotherapy to treat patients diagnosed with malignant peritoneal mesothelioma.

Dr. Konstintinos Leventakos is a medical oncologist with expertise in lung cancer and other thoracic malignancies. He sees patients and conducts research at the Mayo Clinic in Rochester, Minnesota, and is particularly focused on the use of immunotherapy and creating personalized treatment plans based on patients’ unique genetic profile and goals.

Dr. Konstantinos Votanopoulos is a surgical oncologist who specializes in the treatment of malignant peritoneal mesothelioma using the complex surgical procedure known as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, or HIPEC. He sees patients at Wake Forest Baptist Medical Center and Comprehensive Cancer Center in Winston-Salem, North Carolina.

Dr. Kurtis Campbell is a surgical oncologist whose specialties include cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma. He practices at Mercy Medical Center in Baltimore, Maryland.

Dr. Laura A. Lambert is a surgical oncologist and palliative medicine specialist at the University of Utah Health, Huntsman Cancer Institute. She specializes in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal malignancies like mesothelioma.

Dr. Laurence Brinckerhoff is a thoracic surgeon who is widely recognized as an expert in treating patients with lung cancer and malignant pleural mesothelioma. He is the Chief of Thoracic Surgery at Boston Medical Center in Boston, Massachusetts.

Dr. Laxmi Narayana R. Buddharaju is a medical oncologist who treats patients diagnosed with lung cancer, gastrointestinal, and other malignancies at the University of Nebraska Medical Center.

Dr. Krug is a medical oncologist and researcher for AstraZeneca. He recently left the position of director of the Mesothelioma Program at Memorial Sloan Kettering Cancer Center to focus on research. His leadership in research and patient treatment is making real strides in helping patients live longer and more comfortably. Dr. Klug’s clinical and research interests and specialties are the multimodal treatment of mesothelioma and thoracic cancers, vaccine treatments, and leading clinical trials of novel treatment strategies. [17]

Dr. Leopoldo Fernandez is a surgical oncologist who treats peritoneal mesothelioma at the VCU Massey Comprehensive Cancer Center in Richmond, Virginia. He is skilled in the use of hyperthermic intraperitoneal chemotherapy for treating patients with malignant peritoneal mesothelioma.

Dr. Leora Horn is a thoracic oncologist and lung cancer researcher who has dedicated her career to research and the care of patients with lung cancer. After years of directing the Thoracic Oncology program at Vanderbilt-Ingram Cancer Center, she now leads global lung cancer research for AstraZeneca.

Dr. Linda Garland is a thoracic medical oncologist and translational researcher at the University of Arizona and Banner Health in Tucson, Arizona. She specializes in the treatment of patients diagnosed with malignant mesothelioma and lung cancer.

Dr. Linda W. Martin is a thoracic surgeon whose practice focuses on the surgical treatment of lung cancer, malignant pleural mesothelioma, and other thoracic diseases.

Dr. Lorraine D. Cornwell is a thoracic oncologist and surgeon who practices at the Michael E. DeBakey VA Medical Center in Houston, Texas. She specializes in the care of military veterans diagnosed with lung cancer, esophageal cancer, pleural mesothelioma, and other malignancies.

Dr. Argote-Greene is a thoracic and esophageal surgeon and Regional Director of Thoracic and Esophageal Surgery at Cleveland Clinic’s Indian River Hospital. He has co-authored more than 50 peer-reviewed articles and holds professional memberships in the International Association for the Study of Lung Cancer and the Society of Thoracic Surgeons. Dr. Argote-Greene is a pioneer in video-assisted thoracoscopic surgery and became an expert in mesothelioma working under the legendary Dr. David Sugarbaker. [1]

Dr. Luis J. Herrera is a thoracic surgeon and the medical director of the Rod Taylor Thoracic Care Center at the Orlando Health Cancer Institute. He specializes in surgery for thoracic malignancies including lung cancer and mesothelioma, as well as esophageal cancer, chest wall cancer, and mediastinum cancer.

Dr. Lynn D. Wilson is a radiation oncologist at Yale Medicine and the Smilow Cancer Hospital in New Haven, Connecticut. He specializes in treating patients with lung cancers and cutaneous lymphoma.

Dr. Lyudmila Bazhenova is a board-certified medical oncologist who specializes in treating patients with thoracic malignancies and all types of lung cancers. She practices at Moores Comprehensive Cancer Center at UC San Diego in San Diego, California.

Dr. M. Chris Dobelbower is a radiation oncologist who treats patients with lung cancer, pleural mesothelioma, and other thoracic malignancies at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham.

Dr. Madhuri Rao is a thoracic surgeon at the Masonic Cancer Center, University of Minnesota. She specializes in minimally invasive surgery and innovative advances including robotics.

Dr. Malcolm DeCamp is a thoracic surgeon and oncologist at University of Wisconsin Health and the Carbone Comprehensive Cancer Center in Madison, Wisconsin. He specializes in advanced surgical techniques for lung cancer and thoracic malignancies including malignant pleural mesothelioma.

Dr. Manish Patel is a hematologist oncologist at the Masonic Cancer Center, University of Minnesota, who specializes in thoracic oncology, head and neck cancer, and malignant pleural mesothelioma.

Dr. Marcelo DaSilva is board-certified as a critical-care, cardiovascular, and thoracic surgeon and serves as the Medical Director of Thoracic Surgery at Advent Health Orlando. Previously, he worked as a thoracic surgeon at the Brigham and Women’s Hospital and as a surgery instructor at Harvard Medical School. He also did work as a consultant for Boston’s Dana Farber Cancer Institute.

Dr. Maria C. Russell is a surgical oncologist who practices at Emory University and the Winship Cancer Institute in Atlanta, Georgia. Among her surgical skills is the complex procedure that combines cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with malignant peritoneal mesothelioma.

Dr. Mariam Alexander is a medical oncologist at the Hollings Cancer Center and MUSC Health in Charleston, South Carolina. She specializes in treating lung cancer and targeted therapies for solid tumors like malignant pleural mesothelioma.

Dr. Zauderer is a thoracic medical oncologist who is Co-Director of Memorial Sloan Kettering Cancer Center’s Mesothelioma Program. She cares for patients diagnosed with malignant mesothelioma and other thoracic malignancies, taking a personalized approach that puts her patients’ priorities first.

Dr. Mark A. Socinski is a medical oncologist who specializes in pleural mesothelioma and other thoracic malignancies at AdventHealth Cancer Institute in Orlando, Florida.

Dr. Mark E. Ginsburg is a board-certified thoracic surgeon at New York Presbyterian’s Columbia University Medical Center in New York and at Good Samaritan Hospital in Suffern, New York. He specializes in surgery for disorders of the diaphragm and specializes in lung cancer treatment, esophageal diseases, and other diseases of the chest including malignant pleural mesothelioma.

Dr. Mark K. Ferguson is a thoracic and cardiac surgeon. He specializes in surgical management of lung cancer, benign and malignant esophageal diseases, malignant mesothelioma, and other diseases of the chest at the University of Chicago Comprehensive Cancer Center.

Dr. Mark L. Knab is a general surgeon and surgical oncologist at Loyola Medicine and Cardinal Bernardin Cancer Center in Maywood Illinois. He treats cancers of the esophagus, liver, pancreas, stomach, and intestines using robotic and minimally invasive techniques. He treats patients with malignant peritoneal mesothelioma using cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Dr. Mark Richard Dylewski is a thoracic surgeon at Baptist Health South Florida’s Miami Cancer Institute. Considered by many to be a “master” of robotic surgery, he uses innovative techniques in the treatment of thoracic malignancies, including lung cancer and malignant pleural mesothelioma.

Dr. Mark S. Allen is a thoracic surgeon and consultant at the Mayo Clinic in Rochester, Minnesota. His practice includes all aspects of general thoracic surgery, including esophageal cancer, laparoscopic surgery, minimally invasive lung surgery, and surgery for pleural mesothelioma and other thoracic malignancies.

Dr. Marta Batus is a medical oncologist at Rush University Health in Chicago, Illinois. She works with other professionals there to create treatment plans for lung cancer patients.

Dr. Martin Goodman is a surgical oncologist skilled in the specialized procedure called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. He deploys this surgery at Tufts Medicine in Boston, Massachusetts for the treatment of malignant peritoneal mesothelioma.

Dr. Mathew Thomas is a general and cardiothoracic surgeon at the Mayo Clinic’s Jacksonville, Florida site. His primary interest is advancing minimally invasive surgeries of the chest, including for patients with lung cancer and pleural mesothelioma. He is an expert in the management of complex malignant chest wall diseases.

Dr. Matthew J. Schuchert is a thoracic surgeon who specializes in all aspects of thoracic surgical oncology and the care of patients diagnosed with lung cancer and other tumors of the chest, including malignant pleural mesothelioma. He practices at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania.

Dr. Matthew Steliga is a thoracic surgeon specializing in cancer and mesothelioma. He is an instructor and surgeon at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. He trained and taught at the MD Anderson Cancer Center in Houston, a leading facility for the management of mesothelioma. Dr. Steliga specializes in minimally invasive surgeries and is known for providing his patients with multiple treatment options and compassionate care. [27]

Dr. Mazin F. Al-kasspooles is a surgical oncologist and professor at the University of Kansas Medical Center and its Cancer Center. He is one of only a few surgeons skilled in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, which has delivered improved outcomes in the treatment of peritoneal mesothelioma.

Dr. Mecker G. Möller is a surgical oncologist at the University of Chicago Comprehensive Cancer Center. She specializes in abdominal cancers, and has expertise in the complex procedure known as HIPEC for malignant peritoneal mesothelioma.

Dr. Megan McNally is a surgical oncologist whose skillset includes the complex combination procedure known as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. She deploys this treatment to address malignant peritoneal mesothelioma, as well as other advanced cancers. Dr. McNally practices at Saint Luke’s Health System in Kansas City, Missouri.

Dr. Melinda Hsu is a thoracic medical oncologist at the University Hospitals Seidman Cancer Center in Cleveland, Ohio. She specializes in treating patients with lung cancer, thoracic malignancies, and malignant pleural mesothelioma.

Dr. Michael Kluger is a renowned surgeon at Columbia University’s Herbert Irving Comprehensive Cancer Center in New York who specializes in complex surgeries for peritoneal mesothelioma, as well as for the management of diseases of the pancreas, liver, and gallbladder.

Dr. Michael J. Weyant is a thoracic surgeon at Inova Health in Falls Church, Virginia. He specializes in the use of robotic minimally invasive surgical techniques for the treatment of lung cancer and other thoracic diseases, including malignant pleural mesothelioma.

Dr. Michael S. Mulligan is a cardiothoracic surgeon who specializes in thoracic surgery, transplant surgery, and robotic surgery at UW Medicine in Seattle, Washington. His expertise significantly improves outcomes for patients diagnosed with malignant pleural mesothelioma and lung cancer.

Dr. Michael Shafique is a medical oncologist who treats lung cancer and mesothelioma patients at the Moffitt Cancer Center in Tampa, Florida. He specializes in identifying patients’ unique molecular biology to enhance the use and efficacy of immunotherapy.

Dr. Michele Carbone is a board-certified anatomic pathologist and expert in pleural mesothelioma at the University of Hawaii Cancer Center in Honolulu, Hawaii. He specializes in exploring the roots of malignant mesothelioma and the relationship between patient genetics and exposure to asbestos.

Dr. Miguel Alelo-Rivera is a thoracic surgeon who specializes in treating patients with lung and thoracic cancers including malignant pleural mesothelioma. He practices at Henry Ford Health in Detroit, Michigan.

Dr. Minesh Mehta is an internationally respected leader in radiation oncology, proton therapy, and cancer research He is the director of the proton therapy center at Miami Cancer Institute at Baptist Health South Florida in Miami, Florida, where he leads care for patients diagnosed with challenging malignancies including pleural mesothelioma and lung cancer.

Dr. Misako Nagasaka is a thoracic oncologist and researcher at the University of California-Irvine, where she provides expert care for patients diagnosed with malignant pleural mesothelioma and lung cancer, as well as thyroid cancer.

Dr. Missak Haigentz is a thoracic oncologist at the Rutgers Cancer Institute and RWJBarnabas Health who specializes in treating lung and thoracic cancers, mesothelioma, and head and neck cancers.

Dr. Mohamed E. Abazeed is a radiation oncologist and scientist focused on improving outcomes of patients with tumors including lung cancer and malignant pleural mesothelioma. He is the Co-Leader of the Lung Cancer Program at the Lurie Cancer Center of Northwestern University.

Dr. Mohamed Shanshal is a medical oncologist at the Mayo Clinic in Rochester, Minnesota. He specializes in treating thoracic malignancies, including malignant pleural mesothelioma and both non-small-cell and small-cell lung cancer. His research interest lies in drug development for the treatment of these diseases.

Dr. Momen Wahidi is an interventional pulmonologist at Northwestern Medicine and the Lurie Cancer Center in Chicago, Illinois. He closely collaborates with a multispecialty group of physicians to provide high-quality care to patients with lung cancer, malignant pleural mesothelioma, and other airway diseases.

Dr. Muaiad Kittaneh is a medical oncologist at the Loyola University of Chicago and Cardinal Bernardin Cancer Center in Maywood, Illinois. He is a specialist in the treatment of malignant peritoneal mesothelioma, and one of the only physicians in the greater Midwest who offers treatment of the rare, asbestos-related disease.

Dr. Muhammad Furqan is a medical oncologist at the University of Iowa Holden Comprehensive Cancer Center. He specializes in treating patients with lung cancer and other thoracic tumors, including malignant mesothelioma.

Dr. Muhanned Abu-Hijleh is a critical care medicine specialist and pulmonologist who provides care for patients with pleural and lung malignancies at the Harold C. Simmons Comprehensive Cancer Center, as well as treating patients with other respiratory illnesses at UT Southwestern Medical Center.

Dr. Nabil Wasif is a surgical oncologist at the Mayo Clinic in Phoenix, Arizona. He specializes in performing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of malignant peritoneal mesothelioma, as well as other abdominal malignancies.

Dr. Nader N. Hanna is a surgical oncologist at University of Maryland Health System and Medical Director of the UM St. Joseph Medical Center Cancer Institute. As a member of the Mesothelioma and Thoracic Oncology Treatment and Research Center, he cares for patients diagnosed with malignant peritoneal mesothelioma.

Dr. Nasser H. Hanna is a specialist in treating pleural diseases at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center in Indianapolis. He specializes in treating patients suffering from various thoracic cancers, including lung cancer and malignant pleural mesothelioma.

Dr. Nathan Bolton is a surgical oncologist who specializes in peritoneal, gastrointestinal, hepatopancreaticobiliary, and neuroendocrine malignancies. He treats patients at Ochsner MD Anderson Cancer Center in New Orleans, Louisiana.

Dr. Pennell is director of the Taussig Cancer Center’s lung cancer medical oncology program. A board-certified medical oncologist, he specializes in treating thoracic malignancies, including malignant mesothelioma and lung cancer. He is also a professor of medicine at the Cleveland Clinic Lerner College of Medicine.

Dr. Neil A. Christie is a thoracic and cardiothoracic surgeon who specializes in minimally invasive surgery at the University of Pittsburgh Medical Center. He provides expert care for patients diagnosed with pleural mesothelioma and lung cancer.

Dr. Nestor Ricardo Villamizar is a thoracic surgeon specializing in state-of-the-art surgical techniques for the treatment of all diseases and conditions of the chest. Working at Sylvester Comprehensive Cancer Center in South Florida, he offers multimodality therapy for locally advanced lung cancer, malignant pleural and peritoneal mesothelioma, and other cancers.

Dr. Nikolaos A. Dallas is a general and oncologic surgeon with expertise in complex techniques for peritoneal malignancies, including malignant peritoneal mesothelioma. He practices at Advocate Medical Group in Chicago, Illinois.

Dr. Omar H. Llaguna is a surgical oncologist with the Memorial Healthcare System in Pembroke Pines, Florida. He leads the Peritoneal Surface Malignancy Program and treats patients with malignant peritoneal mesothelioma.

Dr. Omeed Moaven is a surgical oncologist and assistant professor at LSU Health New Orleans and University Medical Center in New Orleans, Louisiana. He is skilled in innovative surgical techniques specific to the care of pancreatic and hepatobiliary cancers and has expertise in the use of HIPEC for the treatment of malignant peritoneal mesothelioma.

Dr. Pasi A. Jänne is a medical oncologist at the Dana-Farber Cancer Institute in Boston. He treats patients diagnosed with lung cancer and malignant mesothelioma and is a leading researcher on the mechanisms of targeted cancer therapies.

Dr. Patricia Thistlethwaite is a cardiothoracic surgeon skilled in the application of minimally invasive surgical procedures for the treatment of malignant pleural mesothelioma, lung cancer, and other thoracic malignancies. She practices at Moores Comprehensive Cancer Center at UC San Diego, in San Diego, California.

Dr. Patricio Polanco is a surgical oncologist specializing in robotic and minimally invasive surgical techniques at UT Southwestern Medical Center and the Harold C. Simmons Comprehensive Cancer Center in Dallas. His expertise includes cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with malignant peritoneal mesothelioma.

Educated in Ireland, Dr. Forde treats patients with lung cancers, mesothelioma, and other thoracic cancers. He is Co-Director of the Division of Upper Aerodigestive Malignancies in the Department of Oncology at Johns Hopkins and directs the multidisciplinary Thoracic Oncology Clinical Research Program.

Dr. Patrick Sinkam is a pulmonary medicine and critical care specialist who focuses on treating patients with lung cancer and chronic obstructive pulmonary disease (COPD), as well as other thoracic cancers. He practices at the VCU School of Medicine in Richmond, Virginia.

Dr. Paul F. Mansfield is a surgical oncologist with the University of Texas at M.D. Anderson Cancer Center in Houston, Texas. He treats patients with malignant peritoneal mesothelioma, specializing in the use of  cytoreductive surgery combined with a specialized administration of heated chemotherapy that has been proven to extend patient survival.

Dr. Paul H. Schipper is a thoracic surgeon at the Knight Cancer Institute. He specializes in the use of minimally invasive techniques to treat patients with lung cancer, esophageal cancer, and pleural mesothelioma.

Dr. Sugarbaker’s renown comes from his years of service as a clinical investigator, lecturer, and mentor as well as a colorectal cancer surgeon and gastrointestinal oncologist. He is also an expert in rare disorders such as peritoneal carcinomatosis, peritoneal mesothelioma, abdominal sarcomas, and pseudomyxoma peritonei. He has spearheaded the development and use of specialized treatments such as cytoreductive surgery using heated intraoperative intraperitoneal chemotherapy and hyperthermia techniques utilizing the Thermotron RF-8. He is also widely published, with over 780 academic journal articles, textbook chapters, and textbooks including a text about sarcoma surgery which has been published in five different languages. [29]

Dr. Pavan Mukesh Jhaveri is a radiation oncologist and member of the mesothelioma and lung cancer treatment team at the Dan L. Duncan Comprehensive Cancer Center of Baylor College of Medicine in Houston, Texas.

Dr. Perry Shen is a surgical oncologist who performs the complex HIPEC procedure for patients with malignant peritoneal mesothelioma. he practices at Wake Forest Baptist Center and Comprehensive Cancer Center in Winston-Salem, North Carolina.

Dr. Peter G. Shields is a medical oncologist and researcher specializing in the treatment of lung cancer. He is the Deputy Director of The Ohio State University Comprehensive Cancer Center in Columbus, Ohio.

Dr. Peter J. Kneuertz is a thoracic surgeon and associate professor in the Division of Thoracic Surgery at Ohio State University. He specializes in performing minimally invasive surgeries on patients with lung cancer, esophageal cancer, and other thoracic malignancies.

Dr. Petr F. Hausner is a medical oncologist whose clinical specialties include thoracic and gastrointestinal oncology. He treats patients diagnosed with lung cancer and both pleural and peritoneal mesothelioma.

Dr. Philp W. Carrott is a thoracic surgeon who practices at UVA Health and UVA Comprehensive Cancer Center in Charlottesville, Virginia. He specializes in the use of minimally invasive surgical techniques to treat patients diagnosed with lung cancer, malignant pleural mesothelioma, esophageal cancer, and chest wall tumors.

Dr. Prakash K. Pandalai is a surgical oncologist at the University of Kentucky and The Markey Cancer Center in Lexington, Kentucky. He provides surgical care for patients with complex gastrointestinal malignancies and peritoneal surface cancers like malignant peritoneal mesothelioma. He has extensive experience in HIPEC and other novel treatments.

Dr. Prakash Neupane is a medical oncologist at the University of Kansas Medical Center in Kansas City, Kansas. He specializes in the care of patients with head and neck cancers as well as thoracic cancers including malignant pleural mesothelioma and lung cancer.

Dr. Pranshu Mohindra is a radiation oncologist practicing at University Hospitals in Cleveland, Ohio. He specializes in the treatment of thoracic malignancies including lung cancer and malignant pleural mesothelioma, as well as gynecological, and hemato-lymphoid malignancies.